{"blog": [], "keywords": [{"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "rank": "1", "is_major": "N"}, {"value": "Perrigo Company", "name": "organizations", "rank": "2", "is_major": "N"}, {"value": "Shareholder Rights and Activism", "name": "subject", "rank": "3", "is_major": "N"}, {"value": "Starboard Value LP", "name": "organizations", "rank": "4", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/09/14/business/dealbook/hostile-takeover-battle-can-weaken-a-companys-defenses.html", "document_type": "article", "byline": {"person": [{"lastname": "CYRAN", "firstname": "Robert", "role": "reported", "organization": "", "rank": 1}], "original": "By ROBERT CYRAN"}, "type_of_material": "News", "multimedia": [], "section_name": "Business Day", "word_count": "381", "source": "The New York Times", "subsection_name": "DealBook", "lead_paragraph": "Companies like Perrigo, AstraZeneca and DuPont have recently fought hostile bidders, leaving an opening for activist investors to force change.", "pub_date": "2016-09-14T04:00:00+0000", "news_desk": "Business", "headline": {"kicker": "Breakingviews", "main": "Hostile Takeover Battle Can Weaken a Company\u2019s Defenses", "content_kicker": "Breakingviews"}, "print_page": null, "snippet": "Companies like Perrigo, AstraZeneca and DuPont have recently fought hostile bidders, leaving an opening for activist investors to force change....", "_id": "57d83a4495d0e021d7985fff", "slideshow_credits": null, "abstract": null}